Procter & Gamble (PG) Delivers Mixed Q4 Results as Shares Decline 3-4%

Key Takeaways

• Revenue fell short of expectations: Q4 FY2026 net sales reached $21.2 billion, up 2% year-over-year but missing the consensus estimate of approximately $21.38 billion.
• Core EPS narrowly beat estimates: Adjusted core earnings per share (EPS) came in at $1.43, edging past the analyst consensus of $1.42, though declining 3% from $1.48 in the prior-year quarter.
• Organic sales were flat: Organic sales growth — a key metric that strips out currency fluctuations, acquisitions, and divestitures — registered 0%, with volume, pricing, and mix all neutral in the quarter.
• Margins under pressure: Core operating margin contracted 130 basis points year-over-year, marking the third consecutive quarter of margin compression, driven by higher SG&A (selling, general and administrative) costs and commodity inflation.
• FY2027 guidance disappointed: Management issued fiscal 2027 core EPS guidance of $6.89 to $7.11, with a midpoint of $7.00, slightly below consensus, while projecting total sales growth of just 1% to 3%.
• Shares declined sharply: PG stock fell approximately 3% to 4% in intraday trading following the release, reflecting investor concern over the soft revenue print and cautious forward outlook.

Earnings Context and Why It Matters

Procter & Gamble’s fourth-quarter fiscal 2026 results, reported on July 29, 2026, provide a useful window into the consumer staples sector during a period of ongoing macroeconomic pressure. As one of the largest consumer packaged goods companies—with well-known brands such as Tide, Pampers, Gillette, and Crest—PG serves as a useful indicator of household spending and broader consumer trends. This report is particularly relevant given persistent inflation, elevated commodity costs partly linked to geopolitical tensions, and more price-sensitive consumers who are shifting toward value options in some categories. With full-year organic sales growth slowing to 1% (down from 2% in FY2025 and 4% in FY2024), investors are watching closely to see whether PG can restore volume growth while maintaining profitability.

Reported Results

For the fourth quarter of fiscal 2026 ended June 30, 2026, Procter & Gamble reported net sales of $21.2 billion, a 2% increase from $20.9 billion in the prior-year period. The top line nonetheless came in below the analyst consensus of approximately $21.38 billion. Foreign exchange added about one percentage point to growth, while volume, pricing, and mix were neutral overall, leaving organic sales flat year-over-year.

GAAP diluted net EPS declined 15% to $1.26, affected by lower gross margins and higher SG&A expenses. Core EPS, which excludes certain one-time items, fell 3% to $1.43 but still edged past the consensus of $1.42. On a currency-neutral basis, core EPS declined 5% from the prior year. Net earnings totaled $3.04 billion, down 16% from $3.62 billion a year earlier.

Segment results were mixed. Beauty delivered 4% organic sales growth, supported by mid-single-digit gains in hair care and skin and personal care. Grooming and Fabric & Home Care were flat organically, Health Care declined 1%, and Baby, Feminine & Family Care posted a 2% organic sales drop as both volume and pricing weakened. I also checked this using Tickeron’s AI Screener to see how PG stacks up against peers in the sector.

For the full fiscal year 2026, PG reported net sales of $87.0 billion (up 3%) and core EPS of $6.89 (up 1%). Operating cash flow reached $19.6 billion, and the company returned more than $15 billion to shareholders through $10.2 billion in dividends and $5.0 billion in share repurchases. The April 2026 dividend increase marked the 70th consecutive year of dividend growth.

Market Reaction and Investor Sentiment

Investors reacted negatively to the results, with PG shares declining roughly 3% to 4% in Wednesday trading. Although the small core EPS beat provided a modest positive, the revenue miss and cautious fiscal 2027 outlook weighed more heavily on sentiment. Management highlighted roughly $1 billion in after-tax headwinds from higher raw material, energy, and transportation costs, partly tied to Middle East developments and oil prices near $90 per barrel. With organic sales stalled and three of five segments showing flat or negative growth, the market focused on the durability of top-line momentum and margin resilience. From what I see, the reaction underscores that investors are prioritizing sustained revenue growth over a one-penny EPS beat in the current environment.

Forward Outlook and Key Factors to Monitor

Looking ahead to fiscal 2027, Procter & Gamble expects organic sales growth of 1% to 3% and core EPS between $6.89 and $7.11, implying flat to 3% growth versus fiscal 2026. Management noted that the first quarter is likely to be the most difficult, with EPS expected to decline at least 5% year-over-year before conditions improve later in the year.

Key variables include the path of commodity costs, especially crude oil, which affects raw materials, energy, and transportation. The company is budgeting for approximately $1 billion in after-tax commodity headwinds, or about $0.56 per share—an 8% drag on core EPS growth. Consumer behavior will also matter, particularly as lower-income households continue to seek value and private-label options. The Beauty segment has held up well, but softness in Grooming, Health Care, and Family Care deserves attention.

Productivity efforts remain central. PG achieved 340 basis points of productivity savings in fiscal 2026 and plans to fund reinvestments through further efficiency gains. E-commerce, which grew 6% and now accounts for 20% of sales, is another area of focus. I’m watching this closely as digital channels continue to evolve. Investors should track quarterly organic sales trends, segment volume performance, and margin trends throughout the year.

Using Tickeron’s AI Tools in My Research

When evaluating earnings reports like this one, I find it helpful to run quick comparisons with Tickeron’s AI Screener. The tool lets me filter stocks by industry, market cap, technical signals, and other criteria to see how PG and similar names are performing relative to peers. It saves time and surfaces ideas I might otherwise miss during earnings season.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Contributor

Arthur Evans|Expert

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.

Notable companies

Industry description

Market Cap

High and low price notable news

Volume